We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
While it seems certain Croatian generic drugmaker Pliva will have new owners in the near future, who those owners will be is subject to an escalating bidding war between Barr and Actavis.